The Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) (Prevention) and Control) Bill, 2014, moved by Health Minister J P Nadda, was passed in the Upper House by a voice vote.
During the debate on the measure, many members suggested amending the Section 14(1) of the bill, to remove the phrase "as far as possible" for providing medical treatment by the Centre and the states to those infected with HIV and AIDS.
Stessing the government's commitment to the issue, the minister said "India will treat anyone with HIV and AIDS. Anyone in India having HIV or AIDS, the Government of India will take care of the treatment."
He said there will be a provision in the rules to provide justification for denying treatment to the patients.
The section says: "The measures to be taken by the Central or State Governments under Sector 13 shall include measures for providing as far as possible, anti-retroviral therapy and opportunistic management to people living with HIV or AIDS."
The minister said the passage of the bill made this day a "historic day" because the government can now ensure better quality of life to people living with these diseases.
Congress member Jairam Ramesh had said during the debate that the government has provided Rs 2,000 crore for the scheme for 2017-18 which should be raised to higher levels.
The bill was introduced in the Upper House in 2014 and
then referred to the Parliamentary Standing Committee which gave its report in 2015.
According to the measure, India at present is estimated to have 2.39 million people living with HIV/AIDS, the third highest number after South Africa and Nigeria.
Nadda said the bill provides for the appointment of one or more ombudsman in every state, for which the central government will circulate uniform guidelines.
He said the number of employees in a health institutions for appointment of ombudsmand has been reduced to 20 or more employees from earlier provision of 100 or more in cases where the incidence of infection is high.
He explained that this number has been arrived at rationally after taking into consideration the suggestions of the Parliamentary Standing Committee which examined the bill.
There is a penalty to the tune of Rs one lakh for breach of confidentiality of the patients detail.
The bill says it important for the high-risk groups to access services such as treatment of sexually transmitted infections, HIV testing, condoms, clean needles and syringes to prevent HVI transmission to general public.
It is also necessary to address the issue of stigma faced by those infected by HIV and AIDS, to ensure confidentiality and privacy while providing HIV and AIDS related services and recognise the need to safeguard the rights of these patients in both private and public firms, it added.
Since patients have low immunity, he said they should not be exposed to security jobs and others, where there are high chances of getting injured.
D Raja (CPI) demanded removal of the phrase 'as far as possible' and suggested strengthening of domestic pharma companies to manufacture medicines to cure the diseases.
Fernandes said the country is supplying HIV/AIDS
medicines to 180 countries and has research capabilities to come out with vaccines to cure the disease.
R Laxmanan (AIADMK) emphasised the need to provide equal right for medical treatment as only 25 per cent of those affected got treatment out of 21 lakh infected people in India, which was much less than the global average of 41 per cent.
V Vijayasai Reddy (YSRCP) said there is a difference of opinion between the Home Ministry and Health Ministry on the issue of treating AIDS patients on par with others in security forces.
K Somaprasad (CPI-M), Ashok Siddharth (BSP), Prabhakar Kore (BJP), D Bandyopadhyay (TMC), Naresh Aggarwal (SP), Tiruchi Siva (DMK) and M V Rajeev Gowda (Cong) participated in the debate.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
